The estrogen replacement therapy of the Women’s Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer’s disease
- 1 April 2000
- Vol. 34, S35-S52
- https://doi.org/10.1016/s0378-5122(00)00107-9
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Use of menopausal estrogens and medroxyprogesterone in the United States, 1982–1992Published by Wolters Kluwer Health ,2000
- Equilin, a Principal Component of the Estrogen Replacement Therapy Premarin, Increases the Growth of Cortical Neurons via an NMDA Receptor-Dependent MechanismExperimental Neurology, 1997
- A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's diseaseNeurology, 1997
- 34 Hormone therapy in dementia prevention: The women's health initiative memory StudyNeurobiology of Aging, 1996
- Estrogen replacement therapy and risk of Alzheimer diseaseArchives of internal medicine (1960), 1996
- Effect of oestrogen during menopause on risk and age at onset of Alzheimer's diseaseThe Lancet, 1996
- Is There a Role for Estrogen Replacement Therapy in the Prevention and Treatment of Dementia?Journal of the American Geriatrics Society, 1996
- "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteriJournal of Clinical Endocrinology & Metabolism, 1996
- Estrogen Use and Verbal Memory in Healthy Postmenopausal WomenObstetrics & Gynecology, 1994
- Variations in memory function and sex steroid hormones across the menstrual cyclePsychoneuroendocrinology, 1992